RSPHInvesco S&P 500 Equal Weight Health Care ETF
Sector & Thematic ETF · Invesco
Holdings as of Apr 30, 2026
RSPH is a Sector & Thematic ETF from Invesco holding 59 positions as of Apr 30, 2026, with $776M in assets and a 0.4% net expense ratio. Its largest positions are CNC (2.7%), HUM (2.5%) and UNH (2.3%); the top 10 holdings account for 21.5% of the portfolio. It yields 0.65% on a trailing-12-month basis.
- Issuer
- Invesco
- Holdings
- 594.6% cash, collateral & derivative positions excluded
- Net Assets
- $776METF assets as of 2026-08-10
- Expense Ratio
- 0.4%per latest SEC prospectus filing
- TTM Yield
- 0.65%trailing 12-month distributions
Performance
- 1M
- +3.0%
- YTD
- +12.0%
- 1Y
- +28.4%
- 3Y (ann.)
- +7.0%
- 5Y (ann.)
- +3.5%
- 10Y (ann.)
- +8.9%
A $10,000 investment 10 years ago would be worth $23,479 today at the 10Y annualized rate. This is a backward-looking illustration, not a forecast. Project its future growth →
Total returns including dividends as of 2026-08-07. 3Y/5Y/10Y annualized. Past performance does not predict future results.
Sector Breakdown
| Health Care | 100.5% |
|---|---|
| Other Sectors | 0.0% |
Top 25 Holdings
| # | Holding | Weight |
|---|---|---|
| 1 |  CNCCentene Corp. | 2.66% |
| 2 |  HUMHumana Inc. | 2.46% |
| 3 |  UNHUnitedHealth Group Inc. | 2.31% |
| 4 |  ELVElevance Health, Inc. | 2.31% |
| 5 |  WSTWest Pharmaceutical Services, Inc. | 2.22% |
| 6 |  CICigna Group (The) | 1.98% |
| 7 |  CVSCVS Health Corp. | 1.96% |
| 8 |  VTRSViatris Inc. | 1.90% |
| 9 |  MTDMettler-Toledo International Inc. | 1.85% |
| 10 |  WATWaters Corp. | 1.85% |
| 11 |  TECHBio-Techne Corp. | 1.83% |
| 12 |  BMYBristol-Myers Squibb Co. | 1.80% |
| 13 |  ALGNAlign Technology, Inc. | 1.79% |
| 14 |  INCYIncyte Corp. | 1.79% |
| 15 |  DVADaVita Inc. | 1.78% |
| 16 |  AAgilent Technologies, Inc. | 1.78% |
| 17 |  SOLVSolventum Corp. | 1.77% |
| 18 |  BIIBBiogen Inc. | 1.77% |
| 19 |  CRLCharles River Laboratories International, Inc. | 1.76% |
| 20 |  EWEdwards Lifesciences Corp. | 1.74% |
| 21 |  STESteris PLC | 1.74% |
| 22 |  PFEPfizer Inc. | 1.74% |
| 23 |  HSICHenry Schein, Inc. | 1.73% |
| 24 |  BAXBaxter International Inc. | 1.73% |
| 25 |  DGXQuest Diagnostics Inc. | 1.72% |
Showing the top 25 of 59 holdings. See the full RSPH holdings list →
RSPH alternatives
The closest Sector & Thematic ETFs to RSPH by portfolio overlap — the share of weight both funds hold in the same securities.
| Fund | Overlap | Expense | Assets | |
|---|---|---|---|---|
 XLVState Street® Health Care Select Sector SPDR® ETF | 53% | 0.08%cheaper | $41.9B | Compare → |
| 50% | 0.08%cheaper | $3.3B | Compare → | |
 VHTVanguard Health Care Index Fund | 49% | 0.09%cheaper | $18.3B | Compare → |
 IYHiShares U.S. Healthcare ETF | 48% | 0.38%cheaper | $3.7B | Compare → |
 IHIiShares U.S. Medical Devices ETF | 23% | 0.38%cheaper | $3.4B | Compare → |
 XTiShares Future Exponential Technologies ETF | 13% | 0.46%pricier | $3.9B | Compare → |
 IBBiShares Biotechnology ETF | 13% | 0.44%pricier | $9.3B | Compare → |
 XBIState Street® SPDR® S&P® Biotech ETF | 9% | 0.35%cheaper | $10.0B | Compare → |
Frequently Asked Questions
What is RSPH's expense ratio?
RSPH has a net expense ratio of 0.4%, per its latest SEC prospectus filing. That works out to about $40 a year on a $10,000 investment.
How many holdings does RSPH have?
RSPH held 59 positions as of Apr 30, 2026, per its latest official holdings data. Cash, collateral and derivative positions (4.6% of portfolio weight) are excluded from that count.
What are RSPH's top 10 holdings?
RSPH's largest positions are CNC (2.7%), HUM (2.5%), UNH (2.3%), ELV (2.3%), WST (2.2%), CI (2.0%), CVS (2.0%), VTRS (1.9%), MTD (1.8%), WAT (1.8%). Together they account for 21.5% of the portfolio.
What is RSPH's dividend yield?
RSPH yields 0.65% based on its trailing 12-month distributions, as of Aug 7, 2026.
How big is RSPH?
RSPH has $776M in assets as of Aug 10, 2026.
What are good alternatives to RSPH?
By portfolio overlap, the closest Sector & Thematic ETFs to RSPH are XLV (53% overlap), FHLC (50% overlap), VHT (49% overlap). Overlap measures the share of portfolio weight both funds hold in the same securities.